So, it was a surprise when two of the biggest players in the GLP-1 market, Novo Nordisk and Eli Lilly, announced that they are going to offer GLP-1s directly to consumers
However, your healthcare provider may modify this timeline based on your individual response
PCT Int
Cardiovascular, mortality, and kidney outcomes with GLP1 receptor agonists in patients with type 2 diabetes: a systematic review and metaanalysis of randomised trials
While the pharma industry attempts to expand the improved GLP-1 drug market, including orals, the generics industry will grow its GLP-1 agonist foothold, making cheaper and less efficacious injectable GLP-1 drugs much more widely available, rapidly growing the number of patients comfortable with self-injection for weight loss
Length is individualized based on response and clinical progression